Anesteziologie a intenzivní medicína, 2002 (vol. 13), issue 3

Ultrafast Short-acting Beta Blocker Esmolol (Brevibloc (R) ) for Perioperative Myocardial ProtectionArticles

B. Jurenka, O. Biebl, V. Kubricht, M. Stern, J. Šoupal

Anest. intenziv. Med. 2002;13(3):100-102

The authors deal with the complex pharmacological control of sympathetic activation in high risk patients in the risk for the perioperative myocardialischemia. As the part of the perioperative myocardial protection the authors present ultrafast short-acting beta blocker esmolol (Brevibloc  ). Itsapplication, as the part of the complex myocardial protection, decreases incidence of the perioperative myocardial ischemia in patients with theabdominal aortic surgery.

Office-based Anaesthesia for Dentistry in the Disabled: Rotterdam ApproachArticles

J. Rupeht, E. C. M. Bouvy-Berends

Anest. intenziv. Med. 2002;13(3):103-105

Dentistry for profoundly disabled patients has been hampered in the Netherlands by the chronic shortage of available anaesthetic care within thefew hospitals which provide it. In the Rotterdam region, two fully equipped office-based dental anaesthesia centres have been established. Profoundlyhandicapped patients are assessed preoperatively by four experienced and dedicated anaesthetists. The anaesthetic assistants are also always the samein order to accumulate experience. Dentists and their assistants are taught essentials of co-operation with the anaesthetist in a special course aboutanaesthesia for dentists. It has been shown that dental care performed...

Patient with Haematologic Malignity and Sepsis with Multiorgan FailureArticles

J. Polívková, J. Závada, H. Popelíková, Z. Ehler

Anest. intenziv. Med. 2002;13(3):106-110

Sepsis with multiorgan failure in patients with haematologic malignity is associated with high mortality. It is caused by the specific basic diseaseand marked decrease in the function of the immune system induced by the aggressive therapy. The authors try to describe principal problems andtherapeutic possibilities.

Severe Complication of Inserting Central Venous Dialysis Catheter in Patient with Haematologic MalignityArticles

V. Mixa, K. Cvachovec, D. Sumerauer, J. Mališ, I. Hurychová, M. Vyhnánek, Z. Hríbal

Anest. intenziv. Med. 2002;13(3):111-114

Chemotherapy with subsequent autologous haematopoietic cells transfer is efficient therapeutic modality for some types of malignant blood disorders.Chemotherapy requires double-lumen central venous dialysis catheter which has to be inserted in critically ill patients with pancytopenia, anemia andsevere blood coagulation disorder. The case report shows the haemothorax made by inserted dialysis catheter in patient with PNET kidney. It wascaused by repeated punction of the subclavian vein wall and the severe coagulation disorder. The resuscitation of circulation followed and lasted severalhours including massive volume and inotropic therapy. It was followed...

Prognostic Value of Some Characteristic Sings in Patients with Haematologic Malignity in Intensive CareArticles

M. Kolár, M. Balík, M. Marková, E. Zikešová

Anest. intenziv. Med. 2002;13(3):115-118

The aim of study was evaluation of the prognostic factors in critically ill patients with haematologic malignity. 39 patients were enrolled in the study.Detailed evaluation is made from data of 24 patients without bone marrow transplantation. The bone marrow transplanted patients were subject ofanother study. All the patients came from the Department of Haematology of University Hospital Královské Vinohrady and the Institue of Haematology and Blood Transfusion. The patients were admitted to the intensive care unit in the Department of Anaesthesiology and Intensive Care of University Hospital Královské Vihohrady between January 1999 and December 2000....

The Complications of Allogenic Haematopoietic Cells Transplantation which Requited Intensive CareArticles

M. Marková, P. Cetkovský

Anest. intenziv. Med. 2002;13(3):119-120

The aim allogenic haematopoietic cells transplantation from bone marrow as well as peripheral blood is to destroy residual disease. This therapeuticmodality is associated with high mortality. The complications include endothelial damage syndrome, graft versus host reaction and infectiouscomplications. The authors describe all the complications in detail.

Intensive Care in Bone Marrow Transplanted PatientsArticles

M. Kolár, M. Balík, M. Marková, E. Zikešová

Anest. intenziv. Med. 2002;13(3):121-123

This study followed another trial which had the relation to the patients without bone marrow transplantation who were admitted to the intensivecare unit due to critical complications. The patients in this study came from the same departments as in the previous study - the Department ofHaematology of University Hospital Královské Vinohrady and the Institute of Haematology and Blood Transfusion. The patients were admitted to theintensive care unit in the Department of Anaesthesiology and Intensive Care of University Hospital Královské Vinohrady between January 1999 andDecember 2000. 15 patients were enrolled in the study (6 patients after autotransplantation...

Influence of All-in-one System on Biological Insulin AvailabilityArticles

Z. Rušavý, R. Suchá, E. Langhamerová, V. Šrámek, S. Lacigová, P. Tešínský

Anest. intenziv. Med. 2002;13(3):124-126

In clinical practice, it is necessary to reduce the daily dose of insulin added to all-in-one system in comparison with the daily dose administered bya linear dosing device (perfusor) in physiological solution. The aim of the study is to asses the influence of the base solution on biological insulinavailability expressed in the value of total insulin using the RIA method, and to monitor the influence of the base solution on total insulin concentrationin time.Methods: 15 measurements of total insulin concentration in physiological solution applied by a linear dosing device (8j Actrapid HM + 20 mlphysiological solution) were carried out in time intervals...

Bronchoalveolar Lavage as a Therapeutic Way for Alveolar ProteinosisArticles

M. Refka, M. Janíková, M. Tonkovicová, J. Machová

Anest. intenziv. Med. 2002;13(3):127-129

Authors attend to case of young woman with alveolar proteinosis. Alveolar proteinosis is infrequent disease, which is repeatedly forgotten indifferential diagnosis diffuse pneumopathy processes. Complaint has common clinical features than other pulmonary affection. The sole crediblediagnostic method is lung biopsy and sample histologic adjusting. The bronchoalveolar lavage is only efficient therapeutic way today.

Patient with ARDS and Haematologic Malignity - a Case ReportArticles

Z. Kos, R. Janda, E. Polonyová

Anest. intenziv. Med. 2002;13(3):130-132

58-year-old woman was admitted to the ICU due to acute respiratory failure caused by bronchopneumonia. Lung injury fulfilled ARDS criteria.After patient stabilization the haematologic malignity (multiple myeloma) was diagnosed. The presented case report is the contribution to the discussionof intensive care problems in patients with haematologic malignity.

TUR Syndrome - Case ReportsArticles

B. Stibor, J. Mannová, R. Gál, I. Zimová, I. Cundrle

Anest. intenziv. Med. 2002;13(3):133-135

The authors present three case reports of TUR syndrome. It is one of the severe complications of transurethral resection of the prostate. Its clinicalcourse can be different - from only biochemical changes to the life-threatening situation. They describe clinical symptoms and the biochemical changes.The early diagnosis and adequate therapy are the most important measures. The authors also mention limited possibilities for the prevention of thissyndrome.

Public Medial Action as Possibility for Teaching Basic Life SupportArticles

E. Sovová, B. Klementa, E. Kociánová, O. Marek, J. Lukl

Anest. intenziv. Med. 2002;13(3):136-139

The authors present the course of public medial action which aim was to teach basic life support. They summarize questionnaire survey made duringthat action. The results show little public knowledge of basic life support and need for further puclic education in this area.


Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.